静脈内注入ポンプの世界市場2020-2027:製品別(ボリューム、インスリン、注射器、経腸、外来)、疾患別、地域別

◆英語タイトル:Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN084
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、静脈内注入ポンプの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品別(ボリューム、インスリン、注射器、経腸、外来)分析、疾患別分析、地域別分析、競争分析など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・静脈内注入ポンプの世界市場規模:製品別(ボリューム、インスリン、注射器、経腸、外来)
・静脈内注入ポンプの世界市場規模:疾患別
・静脈内注入ポンプの世界市場規模:地域別
・競争分析
【レポートの概要】

Intravenous Infusion Pumps Market Growth & Trends

The global intravenous infusion pumps market size is expected to reach USD 2.26 billion by 2027, registering a CAGR of 5.9% over the forecast period according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are imparting crucial growth of the market as they constitutes Dose-error Reduction Software (DERS) and customized drug libraries. According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.

To improve the safety and efficacy of intravenous infusion pumps, the U.S. FDA took an initiative known as the Infusion Pump Improvement Initiative in 2010, which focuses on supporting the benefits of generic pumps and minimizing the risk associated with it at the same time. FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders. Several government collaborative researchprojects like the Generic Infusion Pump Project are introduced that are aimed at creating new methods for manufacturers for developing software for intravenous medical pumps. National Institute of Standards and Technology is working in collaboration with NCCoE to manufacture wireless medical pumps and such incorporation of various government policies and regulations will in turn propel the market.

The amalgamation of factors like the shift in technology, automation, and standardized dosing for the intravenous medical devices are anticipated to make therapy more convenient and user-friendly for patients. For instance, in May 2018, Baxter launched SPECTRUM IQ that allows patients records to be transferred directly from the EMR to the infusion system which is apt for home therapy as well as for therapies carried out in hospitals.

The haematology disease indication segment is anticipated to grow fast over the forecast period. Rising cases of blood cancer is driving demand for blood transfusion through haematology, thereby driving the segment. North America dominated the market in 2019 and is anticipated to maintain its dominance over the forecast period. Increasing number of surgeries, rising cases of chronic diseases, and R&D in healthcare sector is driving the market in the region.

Intravenous Infusion Pumps Market Report Highlights

• Ambulatory infusion pumps emerged as the largest product segment in 2019 owing to increasing use of delivery fluids such as nutrients and medications in case of emergencies and treatments like chemotherapy

• The implantable infusion pumps segment is projected to register the highest CAGR over the forecast period as they offer advantages such as improved safety

• The pediatrics/ neonatology segment dominated the market in 2019 in terms of disease indication as there has been growing incidences of premature birth and hence require optimum care and nutrition

• In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Disease Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and Disease Indication scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increasing geriatric population
3.3.1.2. Rising prevalence of chronic diseases
3.3.1.3. Recent technological advancements in infusion pumps
3.3.1.4. Home healthcare as cost effective alternative
3.3.1.5. Improving healthcare infrastructure in emerging economies
3.3.2. Market Restraint Analysis
3.3.2.1. Product recall
3.3.2.2. Presence of complicated reimbursement framework and reimbursement cuts
3.3.3. Industry Challenges
3.3.3.1. Rising cost of Intravenous Infusion Pumps
3.4. Intravenous Infusion Pumps: Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Intravenous Infusion Pumps Market: Segment Analysis, by Product, 2016 – 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Intravenous Infusion Pumps Market , by Product, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027for the following
4.5.1. By product
4.5.1.1. Volumetric Infusion pumps
4.5.1.2. Insulin Infusion pumps
4.5.1.3. Syringe Infusion pumps
4.5.1.4. Enteral Infusion pumps
4.5.1.5. Ambulatory Infusion pumps
4.5.1.6. Patient Controlled Analgesics (PCA)
4.5.1.7. Implantable Infusion pumps
4.5.1.8. Others
Chapter 5. Intravenous Infusion Pumps Market: Segment Analysis, By Disease Indication, 2016 – 2027 (USD Million)
5.1. Definitions & Scope
5.2. Disease Indication market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Intravenous Infusion Pumps Market, By Disease Indication, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Chemotherapy
5.5.2. Diabetes
5.5.3. Gastroenterology
5.5.4. Analgesia/Pain Management
5.5.5. Pediatrics/Neonatology
5.5.6. Hematology
5.5.7. Others
Chapter 6. Intravenous Infusion Pumps Market: Regional Market Analysis, by Product, 2016 – 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.7.2. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.7.3. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.8.2. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.3. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.8.13. Sweden
6.8.13.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.8.13.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.9.2. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.3. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.10. Indonesia
6.9.10.1. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.10.2. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.11 Singapore
6.9.11.3. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.11.4. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.12 Philippines
6.9.12.5. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.12.6. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.9.13 Thailand
6.9.13.7. Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.9.13.8. Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10 Latin America
6.10.1 Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.10.2 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.3 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10.4 Brazil
6.10.4.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.4.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10.5 Mexico
6.10.5.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.5.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10.6 Argentina
6.10.6.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.6.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10.7 Colombia
6.10.7.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.7.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.10.8 Chile
6.10.8.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.10.8.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11 Middle East and Africa
6.11.1 Market estimates and forecast, by country, 2016 – 2027 (USD Million)
6.11.2 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.3 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11.4 South Africa
6.11.4.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.4.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11.5 Saudi Arabia
6.11.5.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.5.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11.6 UAE
6.11.6.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.6.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11.7 Israel
6.11.7.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.7.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
6.11.8 Egypt
6.11.8.1 Market estimates and forecast, by Product, 2016 – 2027 (USD Million)
6.11.8.2 Market estimates and forecast, by Disease Indication, 2016 – 2027 (USD Million)
Chapter 7 Intravenous Infusion Pumps Market – Competitive Analysis
7.1 Key companies profiled
7.1.1 Baxter International
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 B. Braun Melsungen AG
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Medtronic
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Micrel Medical Devices Sa
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Fresenius Kabi
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Boston Scientific corporation
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 CAREFUSION CORPORATION
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Smiths Medical
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Intravenous Infusion Pumps Market, By Region 2016 - 2027 (USD Million)
Table 4 Global Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 5 Global Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 6 North America Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
Table 7 North America Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 8 North America Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 9 U.S. Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 10 U.S. Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 11 Canada Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 12 Canada Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 13 Europe Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
Table 14 Europe Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 15 Europe Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 16 U.K. Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 17 U.K. Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 18 Germany Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 19 Germany Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 20 France Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 21 France Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 22 Italy Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 23 Italy Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 24 Spain Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 25 Spain Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 26 Netherlands Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 27 Netherlands Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 28 Belgium Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 29 Belgium Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 30 Switzerland Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 31 Switzerland Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 32 Russia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 33 Russia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 34 Sweden Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 35 Sweden Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 36 Asia Pacific Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
Table 37 Asia Pacific Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 38 Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 39 India Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 40 India Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 41 Japan Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 42 Japan Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 43 China Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 44 China Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 45 Australia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 46 Australia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 47 South Korea Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 48 South Korea Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 49 Malaysia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 50 Malaysia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 51 Indonesia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 52 Indonesia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 53 Singapore Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 54 Singapore Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 55 Philippines Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 56 Philippines Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 57 Thailand Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 58 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 59 Latin America Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
Table 60 Latin America Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 61 Latin America Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 62 Brazil Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 63 Brazil Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 64 Mexico Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 65 Mexico Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 66 Argentina Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 67 Argentina Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 68 Colombia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 69 Colombia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 70 Chile Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 71 Chile Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 72 MEA Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
Table 73 MEA Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 74 MEA Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 75 South Africa Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 76 South Africa Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 77 Saudi Arabia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 78 Saudi Arabia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 79 UAE Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 80 UAE Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 81 Israel Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 82 Israel Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
Table 83 Egypt Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
Table 84 Egypt Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[静脈内注入ポンプの世界市場2020-2027:製品別(ボリューム、インスリン、注射器、経腸、外来)、疾患別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆